These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2952702)

  • 1. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
    Herrmann HC; Ruddy TD; William G; Strauss HW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside.
    Herrmann HC; Ruddy TD; Dec GW; Strauss HW; Boucher CA; Fifer MA
    Circulation; 1987 Jun; 75(6):1214-21. PubMed ID: 2952373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis.
    Aroney CN; Semigran MJ; Dec GW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1989 Nov; 14(5):1331-8. PubMed ID: 2808990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure.
    Burstein S; Semigran MJ; Dec GW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1992 Oct; 20(4):822-9. PubMed ID: 1527293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
    Chatterjee K; Kereiakes D; Viquerat C; Podolin R
    Am J Cardiol; 1987 Aug; 60(5):37C-41C. PubMed ID: 2956866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
    Kereiakes DJ; Viquerat C; Lanzer P; Botvinick EH; Spangenberg R; Buckingham M; Parmley WW; Chatterjee K
    Am Heart J; 1984 Nov; 108(5):1278-84. PubMed ID: 6238512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.
    Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Bonzel T; Wais U; Lehmann M; Just H
    Circulation; 1989 Jul; 80(1):51-64. PubMed ID: 2525432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linearity of the left ventricular end-systolic pressure-volume relation in patients with severe heart failure.
    Aroney CN; Herrmann HC; Semigran MJ; Dec GW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1989 Jul; 14(1):127-34. PubMed ID: 2738257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Techniques for assessing inotropic effects of drugs in patients with heart failure: application to the evaluation of nicardipine.
    Fifer MA; Aroney CN; Semigran MJ; Herrmann HC; Dec GW; Boucher CA
    Am Heart J; 1990 Feb; 119(2 Pt 2):451-6. PubMed ID: 2405615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure.
    Semigran MJ; Aroney CN; Herrmann HC; Dec GW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1992 Jul; 20(1):98-106. PubMed ID: 1535081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance.
    Crawford MH; Richards KL; Sodums MT; Kennedy GT
    Am J Cardiol; 1984 Apr; 53(8):1051-3. PubMed ID: 6230926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoximone: true inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) catheter technique.
    Thormann J; Hueting J; Kremer P; Wissemann J; Mitrovic V; Dieterich HA; Schlepper M
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1403-15. PubMed ID: 2149060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
    Murakami R; Sano K; Murakami Y; Shimada T; Morioka S
    Int J Cardiol; 1995 Aug; 51(1):57-63. PubMed ID: 8522398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the inotropic function at rest and the effect of enoximone in heart transplanted recipients. Assessment by left ventricular endsystolic pressure volume relationship.
    Heublein B; Auricchio A; Wagenbreth I; Haverich A; Dieterich HA
    J Cardiovasc Surg (Torino); 1992; 33(1):21-7. PubMed ID: 1531987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure.
    Binkley PF; Shaffer PB; Ryan JM; Leier CV
    J Lab Clin Med; 1989 Sep; 114(3):266-71. PubMed ID: 2527935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
    Viquerat CE; Kereiakes D; Morris DL; Daly PA; Wexman M; Frank P; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):326-32. PubMed ID: 3155761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.